177 related articles for article (PubMed ID: 8339390)
1. Detection of adriamycin-induced cardiotoxicity in cultured heart cells with technetium 99m-SESTAMIBI.
Piwnica-Worms D; Chiu ML; Kronauge JF
Cancer Chemother Pharmacol; 1993; 32(5):385-91. PubMed ID: 8339390
[TBL] [Abstract][Full Text] [Related]
2. Divergent kinetics of 201Tl and 99mTc-SESTAMIBI in cultured chick ventricular myocytes during ATP depletion.
Piwnica-Worms D; Chiu ML; Kronauge JF
Circulation; 1992 Apr; 85(4):1531-41. PubMed ID: 1313342
[TBL] [Abstract][Full Text] [Related]
3. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence.
Piwnica-Worms D; Kronauge JF; Chiu ML
Circulation; 1990 Nov; 82(5):1826-38. PubMed ID: 2225379
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of neutral dipolar compounds and lipophilic anions on technetium 99m-hexakis (2-methoxyisobutyl isonitrile) accumulation in cultured chick ventricular myocytes.
Chiu ML; Herman LW; Kronauge JF; Piwnica-Worms D
Invest Radiol; 1992 Dec; 27(12):1052-8. PubMed ID: 1473924
[TBL] [Abstract][Full Text] [Related]
5. Myocardial substrate utilization and left ventricular function in adriamycin cardiomyopathy.
Wakasugi S; Fischman AJ; Babich JW; Callahan RJ; Elmaleh DR; Wilkinson R; Strauss HW
J Nucl Med; 1993 Sep; 34(9):1529-35. PubMed ID: 8355075
[TBL] [Abstract][Full Text] [Related]
6. Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation.
Piwnica-Worms D; Rao VV; Kronauge JF; Croop JM
Biochemistry; 1995 Sep; 34(38):12210-20. PubMed ID: 7547962
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of iodine-123-labeled hypericin and (99m)Tc-labeled hexakis [2-methoxy isobutyl isonitrile] in a rabbit model of myocardial infarction.
Cona MM; Feng Y; Li Y; Chen F; Vunckx K; Zhou L; Van Slambrouck K; Rezaei A; Gheysens O; Nuyts J; Verbruggen A; Oyen R; Ni Y
J Cardiovasc Pharmacol; 2013 Sep; 62(3):304-11. PubMed ID: 23714775
[TBL] [Abstract][Full Text] [Related]
8. Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention.
Crane P; Laliberté R; Heminway S; Thoolen M; Orlandi C
Eur J Nucl Med; 1993 Jan; 20(1):20-5. PubMed ID: 7678396
[TBL] [Abstract][Full Text] [Related]
9. Effect of metabolic inhibition on technetium-99m-MIBI kinetics in cultured chick myocardial cells.
Piwnica-Worms D; Kronauge JF; Delmon L; Holman BL; Marsh JD; Jones AG
J Nucl Med; 1990 Apr; 31(4):464-72. PubMed ID: 2324822
[TBL] [Abstract][Full Text] [Related]
10. Comparison of hypoxia and ouabain effects on the myocardial uptake kinetics of technetium-99m hexakis 2-methoxyisobutyl isonitrile and thallium-201.
Meerdink DJ; Leppo JA
J Nucl Med; 1989 Sep; 30(9):1500-6. PubMed ID: 2527973
[TBL] [Abstract][Full Text] [Related]
11. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex.
Piwnica-Worms D; Chiu ML; Budding M; Kronauge JF; Kramer RA; Croop JM
Cancer Res; 1993 Mar; 53(5):977-84. PubMed ID: 8094997
[TBL] [Abstract][Full Text] [Related]
12. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.
Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M
J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial localization and characterization of 99Tc-SESTAMIBI in heart cells by electron probe X-ray microanalysis and 99Tc-NMR spectroscopy.
Piwnica-Worms DP; Kronauge JF; LeFurgey A; Backus M; Hockett D; Ingram P; Lieberman M; Holman BL; Jones AG; Davison A
Magn Reson Imaging; 1994; 12(4):641-52. PubMed ID: 8057769
[TBL] [Abstract][Full Text] [Related]
14. Myocardial kinetics of 99m technetium-Q agents: studies in isolated cardiac myocyte, isolated perfused rat heart, and canine regional myocardial ischemia models.
McGoron AJ; Biniakiewicz D; Millard RW; Kumar A; Kennedy SC; Roszell NJ; Gabel M; Huth C; Walsh RA; Gerson MC
Invest Radiol; 1999 Nov; 34(11):704-17. PubMed ID: 10548383
[TBL] [Abstract][Full Text] [Related]
15. Applications of 99mTc-sestamibi in oncology.
Maffioli L; Steens J; Pauwels E; Bombardieri E
Tumori; 1996; 82(1):12-21. PubMed ID: 8623497
[TBL] [Abstract][Full Text] [Related]
16. Redistribution of 99mTc-sestamibi and 201Tl in the presence of a severe coronary artery stenosis.
Sinusas AJ; Bergin JD; Edwards NC; Watson DD; Ruiz M; Makuch RW; Smith WH; Beller GA
Circulation; 1994 May; 89(5):2332-41. PubMed ID: 8181159
[TBL] [Abstract][Full Text] [Related]
17. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats.
Hatada K; Riou LM; Ruiz M; Yamamichi Y; Duatti A; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK
J Nucl Med; 2004 Dec; 45(12):2095-101. PubMed ID: 15585487
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of technetium-99m-Sestamibi and thallium-201 in a transient ischemic myocardium animal model: insight into the 'redistribution' phenomenon.
Mousa SA; Cooney JM; Stevens S
Cardiology; 1992; 81(2-3):157-63. PubMed ID: 1286474
[TBL] [Abstract][Full Text] [Related]
19. Enhancement by tetraphenylborate of technetium-99m-MIBI uptake kinetics and accumulation in cultured chick myocardial cells.
Piwnica-Worms D; Kronauge JF; Chiu ML
J Nucl Med; 1991 Oct; 32(10):1992-9. PubMed ID: 1919744
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression.
Cordobes MD; Starzec A; Delmon-Moingeon L; Blanchot C; Kouyoumdjian JC; Prévost G; Caglar M; Moretti JL
J Nucl Med; 1996 Feb; 37(2):286-9. PubMed ID: 8667063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
